The use of direct oral anticoagulants in patients with ventricular assist devices: is there hope for Factor Xa inhibition?

2020 ◽  
Author(s):  
Thomas Meredith ◽  
Bruno Schnegg ◽  
Christopher Hayward
Keyword(s):  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Factor Xa ◽  
Ventricular Assist Devices ◽  
Ventricular Assist ◽  
Assist Devices ◽  
Factor Xa Inhibition

Novel Oral Anticoagulants in Patients with Continuous Flow Left Ventricular Assist Devices

2019 ◽  
Vol 38 (4) ◽  
pp. S425 ◽  
Author(s):  
V. Parikh ◽  
U. Parikh ◽  
A.M. Ramirez ◽  
H. Lamba ◽  
J. George ◽  
...  
Keyword(s):  
Continuous Flow ◽  
Oral Anticoagulants ◽  
Left Ventricular ◽  
Novel Oral Anticoagulants ◽  
Ventricular Assist Devices ◽  
Left Ventricular Assist Devices ◽  
Ventricular Assist ◽  
Assist Devices ◽  
Left Ventricular Assist

scholarly journals Nine contemporary therapeutic directions in heart failure

Heart Asia ◽  
2019 ◽  
Vol 11 (1) ◽  
pp. e011150 ◽  
Author(s):  
Zaid Almarzooq ◽  
Manan Pareek ◽  
Lauren Sinnenberg ◽  
Muthiah Vaduganathan ◽  
Mandeep R. Mehra
Keyword(s):  
Heart Failure ◽  
Oral Anticoagulants ◽  
Direct Oral Anticoagulants ◽  
Scientific Progress ◽  
Left Ventricular ◽  
Ventricular Assist Devices ◽  
Left Ventricular Assist Devices ◽  
Ventricular Assist ◽  
Reduced Ejection Fraction ◽  
Sodium Glucose Cotransporter

The global burden of heart failure has continued to increase dramatically with 26 million people affected and an estimated health expenditure of $31 billion worldwide. Several practice-influencing studies were reported recently, bringing advances along many frontiers in heart failure, particularly heart failure with reduced ejection fraction. In this article, we discuss nine distinct therapeutic areas that were significantly influenced by this scientific progress. These distinct areas include the emergence of sodium-glucose cotransporter-2 inhibitors, broadening the application of angiotensin-neprilysin inhibition, clinical considerations in therapy withdrawal in those patients with heart failure that ‘recover’ myocardial function, benefits of low-dose direct oral anticoagulants in sinus rhythm, targeted therapy for treating cardiac amyloidosis, usefulness of mitral valve repair in heart failure, the advent of newer left ventricular assist devices for advanced heart failure, the role of ablation in atrial fibrillation in heart failure, and finally the use of wearable defibrillators to address sudden death.

Factor Xa inhibitors in patients with continuous-flow left ventricular assist devices

2020 ◽  
Vol 68 (11) ◽  
pp. 1278-1284
Author(s):  
Vishal Y. Parikh ◽  
Umang M. Parikh ◽  
Angel Moctezuma-Ramirez ◽  
Harveen K. Lamba ◽  
Joggy K. George ◽  
...  
Keyword(s):  
Continuous Flow ◽  
Factor Xa ◽  
Left Ventricular ◽  
Ventricular Assist Devices ◽  
Factor Xa Inhibitors ◽  
Left Ventricular Assist Devices ◽  
Ventricular Assist ◽  
Assist Devices ◽  
Left Ventricular Assist

Peritransplant anticoagulation management in patients with left ventricular assist devices

2009 ◽  
Vol 56 (S 01) ◽  
Author(s):  
HA Welp ◽  
JR Sindermann ◽  
S Klotz ◽  
A Rukosujew ◽  
TT Tjan ◽  
...  
Keyword(s):  
Left Ventricular ◽  
Ventricular Assist Devices ◽  
Left Ventricular Assist Devices ◽  
Anticoagulation Management ◽  
Ventricular Assist ◽  
Assist Devices ◽  
Left Ventricular Assist

Acquired Von Willebrand Syndrome (AVWS) and bleeding complications in long-term patients with Ventricular Assist Devices (VAD)

2012 ◽  
Vol 60 (S 01) ◽  
Author(s):  
C Heilmann ◽  
B Zieger ◽  
U Geisen ◽  
G Trummer ◽  
C Benk ◽  
...  
Keyword(s):  
Ventricular Assist Devices ◽  
Bleeding Complications ◽  
Ventricular Assist ◽  
Acquired Von Willebrand Syndrome ◽  
Assist Devices ◽  
Von Willebrand

Reduction of driveline infections through doubled driveline tunneling of left ventricular assist devices (LVAD)

2013 ◽  
Vol 61 (S 01) ◽  
Author(s):  
F Fleissner ◽  
J Schmitto ◽  
M Avsar ◽  
D Malehsa ◽  
M Strüber ◽  
...  
Keyword(s):  
Left Ventricular ◽  
Ventricular Assist Devices ◽  
Left Ventricular Assist Devices ◽  
Ventricular Assist ◽  
Assist Devices ◽  
Left Ventricular Assist

Minimally invasive implantation of left ventricular assist devices improves the outcome in INTERMACS -1 patients

2014 ◽  
Vol 62 (S 01) ◽  
Author(s):  
S.V. Rojas ◽  
B. Fleischer ◽  
M. Avsar ◽  
J.S. Hanke ◽  
P.R. Ahrens ◽  
...  
Keyword(s):  
Minimally Invasive ◽  
Left Ventricular ◽  
Ventricular Assist Devices ◽  
Left Ventricular Assist Devices ◽  
Ventricular Assist ◽  
Assist Devices ◽  
Left Ventricular Assist
Sign in / Sign up

Export Citation Format

Share Document